| Ms Lane Elizabeth Mcclellan, LCSW | |
|
1893 Cliff Gookin Blvd Ste B, Tupelo, MS 38801-6558 | |
| (662) 346-4584 | |
| (662) 346-4589 |
| Full Name | Ms Lane Elizabeth Mcclellan |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 15 Years |
| Location | 1893 Cliff Gookin Blvd Ste B, Tupelo, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013146927 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Counseling For A Cause, Llc | 9335411396 | 4 |
News Archive
A loss of $3.7 million in federal funds is forcing Georgia to reduce its workforce for HIV prevention. After an inquiry by Georgia Health News, the Department of Public Health this week acknowledged that 20 people in state health districts have been notified they will probably lose their jobs in January, and that an unspecified number of staffers at the department level have received the same notification.
Hotspur Technologies, Inc. announced today that it has received FDA clearance for the first three commercial products in its portfolio. These products are based on Hotspur's unique and groundbreaking technology that makes dialysis access interventional and peripheral vascular procedures that open blood vessels less expensive, more efficient, and less invasive for patients.
Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, has published research in Nature Chemical Biology demonstrating the first-ever selective irreversible inhibition of a viral protease using a targeted covalent drug.
ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a new $11.7 million contract by the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC). The contract has a term of three years. The contract is awarded under a CDC National Center for Birth Defects and Developmental Disabilities ID/IQ task order.
Exiqon A/S, a leader in microRNA analysis products and services, and MultiD Analyses AB, a leader in comprehensive software solutions for qPCR data analysis, today announced a Development and Distribution Agreement incorporating a specifically adapted version of the GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform. The agreement allows Exiqon to sell a fully compatible and comprehensive data analysis solution to complete their microRNA qPCR offering.
› Verified 3 days ago
| Entity Name | Counseling For A Cause, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831627405 PECOS PAC ID: 9335411396 Enrollment ID: O20170825001357 |
News Archive
A loss of $3.7 million in federal funds is forcing Georgia to reduce its workforce for HIV prevention. After an inquiry by Georgia Health News, the Department of Public Health this week acknowledged that 20 people in state health districts have been notified they will probably lose their jobs in January, and that an unspecified number of staffers at the department level have received the same notification.
Hotspur Technologies, Inc. announced today that it has received FDA clearance for the first three commercial products in its portfolio. These products are based on Hotspur's unique and groundbreaking technology that makes dialysis access interventional and peripheral vascular procedures that open blood vessels less expensive, more efficient, and less invasive for patients.
Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, has published research in Nature Chemical Biology demonstrating the first-ever selective irreversible inhibition of a viral protease using a targeted covalent drug.
ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a new $11.7 million contract by the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC). The contract has a term of three years. The contract is awarded under a CDC National Center for Birth Defects and Developmental Disabilities ID/IQ task order.
Exiqon A/S, a leader in microRNA analysis products and services, and MultiD Analyses AB, a leader in comprehensive software solutions for qPCR data analysis, today announced a Development and Distribution Agreement incorporating a specifically adapted version of the GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform. The agreement allows Exiqon to sell a fully compatible and comprehensive data analysis solution to complete their microRNA qPCR offering.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Lane Elizabeth Mcclellan, LCSW 2210 Quail Creek Rd, Tupelo, MS 38801-7251 Ph: (662) 844-0999 | Ms Lane Elizabeth Mcclellan, LCSW 1893 Cliff Gookin Blvd Ste B, Tupelo, MS 38801-6558 Ph: (662) 346-4584 |
News Archive
A loss of $3.7 million in federal funds is forcing Georgia to reduce its workforce for HIV prevention. After an inquiry by Georgia Health News, the Department of Public Health this week acknowledged that 20 people in state health districts have been notified they will probably lose their jobs in January, and that an unspecified number of staffers at the department level have received the same notification.
Hotspur Technologies, Inc. announced today that it has received FDA clearance for the first three commercial products in its portfolio. These products are based on Hotspur's unique and groundbreaking technology that makes dialysis access interventional and peripheral vascular procedures that open blood vessels less expensive, more efficient, and less invasive for patients.
Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, has published research in Nature Chemical Biology demonstrating the first-ever selective irreversible inhibition of a viral protease using a targeted covalent drug.
ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a new $11.7 million contract by the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC). The contract has a term of three years. The contract is awarded under a CDC National Center for Birth Defects and Developmental Disabilities ID/IQ task order.
Exiqon A/S, a leader in microRNA analysis products and services, and MultiD Analyses AB, a leader in comprehensive software solutions for qPCR data analysis, today announced a Development and Distribution Agreement incorporating a specifically adapted version of the GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform. The agreement allows Exiqon to sell a fully compatible and comprehensive data analysis solution to complete their microRNA qPCR offering.
› Verified 3 days ago
Tiffany Brown, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2434 S Eason Blvd, Tupelo, MS 38804 Phone: 662-640-4595 Fax: 662-680-6416 | |
Alyssa Bridges, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2434 S Eason Blvd, Tupelo, MS 38804 Phone: 662-640-4595 | |
Caitlyn Bouldin, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2434 S Eason Blvd, Tupelo, MS 38804 Phone: 662-640-4595 | |
Kayla Harris, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2434 S Eason Blvd, Tupelo, MS 38804 Phone: 662-810-4125 | |
Keyaira Standifer, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2434 S Eason Blvd, Tupelo, MS 38804 Phone: 662-640-4595 | |
Mrs. Dorothy Elder Ford, Counselor Medicare: Not Enrolled in Medicare Practice Location: Region Iii Mental Health Center, 2434 South Eason Blvd, Tupelo, MS 38804 Phone: 662-844-1717 Fax: 662-680-6416 | |
Mr. Richard Eugene Dunnam, NCAC II, CADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 920 Boone St, Tupelo, MS 38804 Phone: 662-844-3531 Fax: 662-844-1757 |